Investors

  • 2022-05-06
    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2022
  • 2022-04-08
    NOTIFICATION LETTER TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF 2021 ANNUAL REPORT AND REQUEST FORM FOR NON-REGISTERED HOLDERS
  • 2022-04-08
    NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2021 ANNUAL REPORT AND CHANGE REQUEST FORM FOR REGISTERED SHAREHOLDERS
  • 2022-04-08
    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2022
  • 2022-04-01
    (1) GRANT OF OPTIONS, (2) GRANT OF AWARDS, (3) NON-EXEMPT CONNECTED TRANSACTIONS — PROPOSED AWARD GRANT TO CONNECTED PERSONS, (4) NON-EXEMPT CONNECTED TRANSACTIONS — PROPOSED PERFORMANCE TARGET AWARD GRANT TO CONNECTED PERSONS, (5) INCREASE IN ANNUAL LIMIT UNDER THE POST-IPO SHARE AWARD SCHEME, (6) PROPOSED INCREASE IN SHARE AWARD SCHEME LIMIT UNDER THE POST-IPO SHARE AWARD SCHEME, AND (7) PROPOSED SCHEME MANDATE TO ISSUE SHARES UNDER THE POST-IPO SHARE AWARD SCHEME
  • 2022-03-30
    NEXT DAY DISCLOSURE RETURN
  • 2022-03-29
    PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION
  • 2022-03-29
    ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021
  • 2022-03-28
    APPOINTMENT OF JOINT COMPANY SECRETARY
  • 2022-03-07
    DATE OF BOARD MEETING
 Copyright Everest Medicines 2020  云顶药业(苏州)有限公司 苏ICP备20038571号 |  Terms of Use |  Privacy Policy |  Disclaimers

沪公网安备 31010602006477号